Qincai Dong

876 total citations
13 papers, 131 citations indexed

About

Qincai Dong is a scholar working on Molecular Biology, Infectious Diseases and Hematology. According to data from OpenAlex, Qincai Dong has authored 13 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Hematology. Recurrent topics in Qincai Dong's work include Chronic Myeloid Leukemia Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and interferon and immune responses (2 papers). Qincai Dong is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and interferon and immune responses (2 papers). Qincai Dong collaborates with scholars based in China and Czechia. Qincai Dong's co-authors include Cheng Cao, Jing Yuan, Guangfei Wang, Xuan Liu, Quanbin Xu, Yuanyuan Bai, Yanwen Jin, Hainan Liu, Yan Cui and Xuan Liu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Free Radical Biology and Medicine.

In The Last Decade

Qincai Dong

13 papers receiving 130 citations

Peers

Qincai Dong
Comparison fields: 5 of 60
  • Molecular Biology 77
  • Cell Biology 33
  • Oncology 29
  • Epidemiology 17
  • Infectious Diseases 13
Replace Ishak D. Irwan with:
Ishak D. Irwan United States
Ronnie Ren Jie Low Australia
Sandra Kissing Germany
Mohammad‐Reza Ghasemi Iran
Mathilde Joint France
Gabriele Büchel Germany
Nicolas Soriano France
Robert M. Witwicki Switzerland
Paul Bensadoun France
Yoon Jee Lee South Korea
Ishak D. Irwan United States View profile →
Citations per field, relative to Qincai Dong
Qincai Dong · 1×
Citations per year, relative to Qincai Dong
Qincai Dong · 1×

Countries citing papers authored by Qincai Dong

Since Specialization
Citations

This map shows the geographic impact of Qincai Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qincai Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qincai Dong more than expected).

Fields of papers citing papers by Qincai Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qincai Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qincai Dong. The network helps show where Qincai Dong may publish in the future.

Co-authorship network of co-authors of Qincai Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Qincai Dong. A scholar is included among the top collaborators of Qincai Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qincai Dong. Qincai Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
# Work Indexed citations
1 2
2 2
3 5
4 4
5 6
6 6
7 4
8 4
9 2
10 5
11 3
12 59
13 29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026